Huapeng Neutrons has successfully concluded a new round of funding, securing tens of millions of yuan. This infusion of capital will be pivotal in advancing clinical trial research, fostering the development of innovative boron drugs, and accelerating the commercialization and market penetration of BNCT (Boron Neutron Capture Therapy) equipment.
